DcR3 Antibodies

Santa Cruz Biotechnology provides a broad selection of DcR3 Antibodies for advanced research in immunology and cancer biology. DcR3 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DcR3, or Decoy Receptor 3, plays a critical role in modulating immune responses by binding to and neutralizing pro-apoptotic ligands, thereby inhibiting apoptosis in certain cell types. This function is particularly significant in cancer research, as DcR3 can contribute to tumor immune evasion and promote tumor growth. Understanding DcR3's role in various diseases can provide insights into potential therapeutic targets and strategies. Researchers can investigate specific protein interactions and cellular pathways involved in immune regulation through detailed molecular analysis. Advanced visualization techniques enable the examination of DcR3 expression patterns across different tissue types and disease states. Cutting-edge research methods support the exploration of novel therapeutic approaches in cancer treatment. Santa Cruz Biotechnology monoclonal antibodies for DcR3 research continue to support scientific advancement in understanding immune system regulation and cancer biology.